The Role of Mononuclear Chemotaxis Protein-1 on Hypertensive Rat Myocardial Fibrosis and Its Relationship with Transforming Growth Factor-Β

王斌,赵连友,郑强荪,薛玉生,李爱国,姜艳华,李言川,于心亚,尚福军,陈军红,杨静霄,陈永清
DOI: https://doi.org/10.3969/j.issn.1009-7236.2004.05.007
2004-01-01
Abstract:AIM: To investigate the effects of inflammatory fa ctor mononuclear chemotaxis protein-1(MCP-1) and transforming growth factor-β(TGF-β) on myocardial fibrosis during hypertension induced by Nω-nitro-L-arginine methyl ester (L-NAME) administration by observing the fibrosis in the rat heart and the expression of MCP-1 and TGF-β in the heart in order to study the role of inflammation in hypertensive myocardial fibrosis. METHODS: The model of hypertension was established by administration of L-NAME. Fibrosis was evaluated morphometrically. The charactistics of the cardiac muscle were observed with the histological method. MCP-1 and TGF-β were determined by the reverse transcription polymerase chain reaction at the transcriptional level. RESULTS: ①Chronic inhibition of n itric oxide synthase(NOS) increased arterial pressure compared with the control group. ②Chronic inhibition of NOS caused significant interstitial fibrosis and perivascular fibrosis. Collagen volume fractions(CVF) of the 7-day group, 14-day group and 28-day group were 4.45%±0.20%, 5.42%±0.68% and 7.02%± 0.82% respectively, which w ere significantly different from that of the control group(3.12%±0.08%)(P0.05); Perivascular collagen areas(PVCA) were 0.85%±0.09%,1.18%±0.16% and 1.52%±0.20% respectively, which were significantly different from that of the control group(0.51%±0.05%)(P0.05). ③A markedly increased expression of MCP-1 mRNA was observed in the heart tissue on the 3rd day of the treatment and declined with the further L-NAME administration. The levels of MCP-1 mRNA of the 3-day group, 7-day group, 14-day group and 28-day group were 0.82±0.12, 0.38±0.06, 0.31±0.05 and 0.22±0.02 respectively, which were significantly different from that of the control group(0.11±0.01)(P0.05). ④The expression of TGF-β mRNA was increased during chronic inhibition of NOS and sustained at the high level until the 28th day. The level of TGF-β mRNA were 1.13±0.08, 1.52±0.17 and 1.46±0.12 respectively, which were significantly different from that of the control group(0.18±0.02)(P0.05). There was no significant difference between the 3-day group(0.21±0.03) and the control group(0.18±0.02)(P0.05). CONCLUSION:①MCP-1 and TGF-β may be involv ed in the fibrosis during hypertension. ②MCP-1 may play an important role in the initiating fibrosis during hypertension. ③TGF-β may play an important role in the chronic development of the myocardial fibrosis in essential hypertension.
What problem does this paper attempt to address?